Largest Backslide in Immunization Coverage in 30 Years Puts Millions at Risk

 
Vaccine Access Digest

July 2022
Johns Hopkins University
Bloomberg School of Public Health

COVID-19 Pandemic Leads to Continued Backsliding in Immunization Coverage Worldwide

 

The International Vaccine Access Center's mission is to create a more equitable world free from adverse health, economic, and social consequences of vaccine-preventable diseases. The COVID-19 pandemic has created incredible challenges in maintaining access to life-saving vaccines and the effects continue to be profound. According to UNICEF/WHO estimates, this pandemic has led to the largest backslide in vaccination in 30 years, and vaccine coverage dropped in every region. We must refocus our efforts despite the current pandemic, to ensure that vulnerable populations can access immunization services and protect their children against preventable diseases.

- Dr. William Moss, Executive Director at IVAC
The official WHO and UNICEF estimates of national immunization coverage (WUENIC) provide the world’s largest data set on immunization trends for vaccinations against 13 diseases given through regular health systems.
 

Vaccination Coverage Resources
 

VIEW-hub visualizes global immunization coverage


VIEW-hub is a map-based platform for visualizing data about the use, impact, and coverage status for key vaccines including human papillomavirus, typhoid conjugate, pneumococcal conjugate, rotavirus, Hib, measles, and polio vaccines both globally and in the 73 Gavi countries. Based on the most recent estimates by country, the maps show the current backsliding as of 2021 caused by the COVID-19 pandemic. Explore the interactive maps here.
 

New estimates reveal alarming stagnation in global access to pneumococcal conjugate vaccines

Vaccines for pneumonia are critical tools for helping to reduce the number of childhood deaths around the world. The pneumococcal conjugate vaccine (PCV) is a lifesaving vaccine that protects children against pneumonia, the number one infectious killer among children under 5.

According to the recently released WUENIC data, just 51% of infants in the world received a full course of PCV in 2021, showing global access has stagnated since the start of the COVID-19 pandemic.

Read the full article here.
Watch "Voices from the Symposium: ISPPD 2022"
During the 12th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD), IVAC's GAP project interviewed a range of experts on pneumococcal diseases who voiced their strong support to accelerate access to PCVs around the world.
 

New data shows rotavirus vaccine coverage declined in 42 countries
Despite gains in recent years in coverage of rotavirus immunizations, the latest data reveal a backsliding in coverage within 42 countries. Partnerships with organizations like ROTA Council, Shot@Life, and Every Breath Counts have worked hard to accelerate the introduction of rotavirus vaccines in the remaining 79 countries without access to protect children's lives.
 

Explainer video for on how mRNA vaccines work wins a Circle of Excellence Award
IVAC Deputy Director Dr. Rupali Limaye’s explainer video on how mRNA vaccines work won a Circle of Excellence Award from the Council for Advancement and Support of Education (CASE). The video, which is easy for children to understand, helps their parents and caregivers explain vaccines to them. 

? IVAC’s COVID-19 vaccine ambassador training for parents and teachers now available in Spanish. Sign up today!
 

Recent Publications
 

Projected resurgence of COVID-19 in the United States in July—December 2021 resulting from the increased transmissibility of the Delta variant and faltering vaccination
Authors include Shaun Truelove
In this paper, published in eLife, the authors presented the joint efforts of nine modeling teams to provide a six-month projection of the COVID-19 pandemic across the US, in view of the circulation of the more transmissible Delta variant. The results represented a timely assessment of the risk of COVID-19 resurgence in the summer of 2021 when it was conducted in July 2021, and will be of historical interest as an example of modeling efforts to inform real-time decision making during the COVID-19 pandemic. 
Message testing in India for COVID-19 vaccine uptake: What appeal and what messenger are most persuasive?
Authors include Rupali J. Limaye, Daniel J. Erchick, Kristian Balgobin, Alexandra Michel, and Gretchen Schulz
This paper, published in Human Vaccines & Immunotherapeutics, aimed to evaluate the influence of three unique messaging appeal framings of vaccination from two types of messengers on COVID-19 vaccine acceptance in India. The results suggest that all three appeals tested were generally acceptable, as well as the two messenger types, although preference was for the health care provider messenger and health outcome appeal.
Chatbot-Delivered COVID-19 Vaccine Communication Message Preferences of Young Adults and Public Health Workers in Urban American Communities: Qualitative Study
Authors include Rose Weeks, Pooja Sangha, João Sedoc, Sydney White, Alexandra Michel, Jae Hyoung Lee, and Naor Bar-Zeev
In an article, published in JMIR Publications, the authors reviewed the acceptability of messages to be delivered by a chatbot named VIRA from Johns Hopkins University. The study investigated which message styles were preferred by young, urban-dwelling Americans as well as public health workers. Humor and moral appeal in VIRA messages were found to have a negative effect on users’ perceptions of the chatbot. Direct messages and casual, nontechnical language were more likely to appeal to users even with extensive detail provided. By using this feedback, VIRA will be able to improve its communication style to reach a wider audience more effectively.
Copyright © 2022 IVAC, All rights reserved.

For Media Inquiries, contact:
This email address is being protected from spambots. You need JavaScript enabled to view it.


image    image
Twitter
Website
Facebook